Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;14(5):14-21.
Epub 2021 May 1.

A Randomized, Double-blind, Placebo-controlled Clinical Study Investigating the Efficacy and Tolerability of a Peptide Serum Targeting Expression Lines

Thu Q Nguyen  1   2   3 , Alisar S Zahr  1   2   3 , Tatiana Kononov  1   2   3 , Glynis Ablon  1   2   3
Affiliations

A Randomized, Double-blind, Placebo-controlled Clinical Study Investigating the Efficacy and Tolerability of a Peptide Serum Targeting Expression Lines

Thu Q Nguyen et al. J Clin Aesthet Dermatol. 2021 May.

Abstract

Clinical Trial ID: NCT0454597 BACKGROUND: Mimetic wrinkles, commonly referred to as expression lines, form perpendicular to anatomical regions subjected to repeated facial muscle contraction. Neuromodulating peptides have biological activity and can offer a solution to those concerned with expression lines and facial aging. OBJECTIVE: The objective of this randomized, double-blind, placebo-controlled study was to assess the efficacy and tolerability of a line-targeting peptide serum (LTPS) as a stand-alone treatment in improving expression lines and skin health. METHODS: This was an institutional review board-approved study involving healthy subjects. Fifty-five female subjects, 35 to 60 years old, Fitzpatrick Skin Type I to VI, with mild to moderate global face fine lines and wrinkles were recruited. Subjects were randomized to apply LTPS or a placebo serum to their face twice daily for twelve weeks. Short-term efficacy was assessed after fifteen minutes of serum application at baseline. Long-term efficacy and tolerability, self-assessment questionnaire, and VISIA® clinical photography were performed at baseline, Weeks 4, 8, and 12. 3D PRIMOS CR imaging and wrinkle analysis were obtained at baseline and Weeks 8 and 12. RESULTS: The LTPS significantly improved expression lines at fifteen minutes (short term), Weeks 4, 8, and 12 (long term) when compared to the placebo serum as evaluated by a board-certified dermatologist. The LTPS significantly outperformed the placebo serum in improving skin parameters at all time points. VISIA and PRIMOS CR wrinkle analysis substantiated the LTPS's efficacy. LTPS was well-perceived and well tolerated by the subjects. CONCLUSION: This IRB-approved clinical study demonstrated that LTPS was effective in improving expression lines, wrinkles, and skin health after twelve weeks of application.

Keywords: Expression lines; double-blind; neuromodulating peptides; peptide serum; placebo-controlled; prebiotic; randomized study.

PubMed Disclaimer

Conflict of interest statement

FUNDING:The clinical trial described in this manuscript was funded by Revision Skincare. DISCLOSURES:Drs. Nguyen and Zahr and Ms. Kononov are current or past employees of Revision Skincare. Dr. Ablon was the principle investigator for the clinical trial described in this manuscript and reports no conflicts of interest relevant to the content of this article.

Figures

FIGURE 1.
FIGURE 1.
FIGURE 2.
FIGURE 2.
FIGURE 3.
FIGURE 3.
FIGURE 4.
FIGURE 4.
FIGURE 5.
FIGURE 5.
See this image and copyright information in PMC

References

    1. Lemperle G, Holmes RE, Cohen SR, Lemperle SM. A classification of facial wrinkles. Plast Reconstr Surg. 2001;108(6):1735–1750. discussion 1751–1732. - PubMed
    1. Piérard GE, Uhoda I, Piérard-Franchimont C. From skin microrelief to wrinkles. An area ripe for investigation. J Cosmet Dermatol. 2003;2(1):21–28. - PubMed
    1. Kligman AM, Zheng P, Lavker RM. The anatomy and pathogenesis of wrinkles. Br J Dermatol. 1985;113(1):37–42. - PubMed
    1. Hillebrand GG, Liang Z, Yan X, Yoshii T. New wrinkles on wrinkling: an 8-year longitudinal study on the progression of expression lines into persistent wrinkles. Br J Dermatol. 2010;162(6):1233–1241. - PubMed
    1. Zhang L, Falla TJ. Cosmeceuticals and peptides. Clin Dermatol. 2009;27(5):485–494. - PubMed

LinkOut - more resources